Tokyo, Nov. 27 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059882) titled 'A Cross-Sectional Survey to Evaluate the Effectiveness of Regional Medical Collaboration between Primary Care Physicians and Nephrologists on the Management of Chronic Kidney Disease in Japan' on Nov. 26.
Study Type:
Observational
Primary Sponsor:
Institute - Nippon Boehringer Ingelheim Co., Ltd.
Condition:
Condition - Chronic kidney disease(CKD)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The main objective is to compare key clinical practice indicators, such as implementation rates of recommended laboratory tests and guideline awareness, between participating and non-participating primary care physicians.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1. Be a PCP at a clinic in Japan.
2. Be registered on the nationwide M3 platform.
Key exclusion criteria - Self-report nephrology as their primary specialty.
Target Size - 600
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 10 Month 31 Day
Date of IRB - 2025 Year 11 Month 19 Day
Anticipated trial start date - 2025 Year 11 Month 21 Day
Last follow-up date - 2025 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068479
Disclaimer: Curated by HT Syndication.
